Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

New $1.9million Debt Facility Agreed

16th Sep 2011 11:19

RNS Number : 3903O
PuriCore Plc
16 September 2011
 



 

PuriCore plc

("PuriCore" or the "Company" or the "Group")

 

PuriCore Raises $1.9 Million 

MALVERN, PENNSYLVANIA, AND STAFFORD, UK, [16] September 2011 - PuriCore(LSE: PURI), the water-based clean technology company focused on developing and commercialising proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens, today announces that it has closed on a new $1.9 million debt facility with Republic First Bank. The debt will be utilized to finance the working capital requirements associated with the significant increase in Sterilox Food Safety System installations in H2 2011. The facility is structured as a promissory note with an imputed interest rate of 4.25%.

 

Enquiries:

Financial Dynamics PuriCore

Susan Quigley Chris Wightman

Ben Brewerton Executive Chairman

+44 (0) 20 7831 3113 +44 (0) 20 7290 3440

 

 

About PuriCore

PuriCore plc (LSE: PURI) is a water-based clean technology company focused on developing and commercialising proprietary green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment. PuriCore's patented, proprietary technology mimics the human body's production of the natural antimicrobial hypochlorous acid, offering a safe and non-hazardous approach to disinfection and sanitisation. The Company's products are used in a broad range of markets that depend upon controlling contamination, including food retail and foodservice, medical device disinfection, and wound care. Hypochlorous acid is proven to be safe, environmentally friendly, and fast acting against a broad range of infectious pathogens, including major public health threats of C.difficile, E.coli, HIV, Human and Animal Influenza (including H1N1 and H5N1), Legionella, MRSA, M.tuberculosis, Norovirus, and Salmonella. PuriCore is headquartered in Malvern, Pennsylvania, with operations in Stafford and Clevedon, UK.

 

To receive additional information on PuriCore, please visit our website at www.puricore.com, which does not form part of this press release.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGURGBUPGGUQ

Related Shares:

RLM.L
FTSE 100 Latest
Value8,275.66
Change0.00